1. 1) The Japanese Society of Chemotherapy, The Japanese Association for Infectious Diseases, The Japanese Society for Infection Prevention and Control, The Japanese Society for Clinical Microbiology, The Pharmaceutical Society of Japan, The Japanese Society of Pharmaceutical Health Care and Sciences, The Japanese Society of Therapeutic Drug Monitoring, The Japanese Society for Medical Mycology Joint Committee, Jpn. J. Chemother., 65, 654-687 (2017).
2. 2) Sato H., Yakuzaigaku, 71, 290-293 (2011).
3. 3) Ikawa K., Ogata H., Medicine and Drug Journal, 53, 1231-1237 (2017).
4. 4) Ishihara N., Nishimura N., Suyama T., Yamamoto A., Tamaki H., Uemura T., Isobe T., Inagaki F., Iwamoto K., Naora K., Jpn. J. Environ. Infect., 25, 15-21 (2010).
5. 5) Japan Nosocominal lnfections Surveillance, Ministry of Health, Labour and Welfare:〈https://janis.mhlw.go.jp/report/open_report/2019/3/1/ken_Open_Report_201900.pdf〉, cited 20 June, 2021.